WELLS FARGO & COMPANY/MN
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 72971
SAN FRANCISCO, CA
Position in IMDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41
+$32 QoQ
Shares Held
7
+133.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 40 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMDX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $2,228,724,937 across 35 Diagnostics & Research names. IMDX ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,458,431 | $731,198,964 | |
| 2 | DHR |
Danaher Corp /De/
|
2,107,482 | $401,433,168 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,751,220 | $371,171,075 | |
| 4 | NTRA |
Natera, Inc.
|
502,818 | $136,489,944 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
209,092 | $110,074,391 | |
| 6 | LH |
Labcorp Holdings Inc.
|
347,544 | $97,312,320 | |
| 7 | WAT |
Waters Corp /De/
|
168,498 | $63,193,487 | |
| 8 | A |
Agilent Technologies, Inc.
|
462,412 | $61,422,185 |
All Filings in IMDX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41 | 7 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $9 | 3 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9 | 3 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9 | 3 | Shares | Defined | 2025-05-13 | |
| 2024-03-31 | $177 | 61 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $150 | 60 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $180 | 58 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||